Search results

  1. D

    Modified Two-Tiered Testing Enzyme Immunoassay Algorithm for Serologic Diagnosis of Lyme Disease, 2022, Khan et al

    So, this is a big deal, this MTTT. Go to the CDC Lyme website and there are now TWO accepted methods to test positive for Lyme: The conventional 2-tier with an ELISA and Western Blot, and this "new" MTTT. The modified two-tiered test -MTTT - with two first tier or ELISA tests - counts just so...
  2. D

    A diagnostic classifier for gene expression-based identification of early Lyme disease, 2022, Servellita et al

    Looks like a Hopkins endeavor, at least some of its authors. Cool premise for early Lyme, i.e. before IgM's typically kick in with Lyme. Left me a little uncomfortable with emphasis on in-vitro and rodent references, but there's some pedigree here author-wise. 63 is a small sample but may be...
  3. D

    Over 14% of Worldwide Population Has (Had) Lyme

    It got my attention. What for me is possibly even more disconcerting, is I suspect (but do not know) this estimate did not include seronegative Lyme patients. Add those individuals into the mix and that 200 million mark may be lowballing it.
  4. D

    Over 14% of Worldwide Population Has (Had) Lyme

    Or different prevalences of various tick species and Bbsl strains, depending on geography.
  5. D

    Over 14% of Worldwide Population Has (Had) Lyme

    A small correction if you don't mind: Seropositivity doesn't necessarily reflect current infection, it can at best only indicate exposure. That being said, Lyme almost invariably progresses from IgMs to IgGs, so we'd expect everyone who tested positive for past exposure to technically test...
  6. D

    Over 14% of Worldwide Population Has (Had) Lyme

    https://www.bmj.com/company/newsroom/more-than-14-of-worlds-population-likely-has-had-tick-borne-lyme-disease/ If the current world population is 7.9 billion, that would suggest over a billion Lyme infections. A commonly acknowledged portion that stay ill is about 20%. If my math is in the...
  7. D

    Long Covid in the media and social media 2022

    Wish someone asked him about chronic Lyme. I'm getting an uneasy feeling that perhaps he holds LC with the same regard he does chronic Lyme - which is to say not very highly. Hey, but that would at least make him consistent.
  8. D

    Predicting distributions of blacklegged ticks, Lyme disease spirochetes and human Lyme disease cases in the eastern US, 2022, Burtis et al

    CDC needs to be helping develop better diagnostics, not wasting its time playing with models. High-predictive models that say Lyme cannot be in a given county or state, or are less likely to be there, are meaningless to the individuals who contract it in those counties and states. Historically...
  9. D

    Management and clinical outcomes of Lyme disease in acute care facilities in 2 endemic regions of Quebec, Canada:, 2022, Musonera et al

    I'd have preferred if this attempt to study the clinical course of Lyme disease included more late stage cases. Only 15 percent of this retrospective's cohort were late stage. So 85 percent was either early or early disseminated. Early stage is different, just as it is with Syphilis - not just...
  10. D

    Sooner or Later, We’ll All Belong to the Kingdom of the Sick (Interview with Meghan O'Rourke, author of The Invisible Kingdom)

    Beyond her book, she has a bunch of salient essays in good journals like the Atlantic. In what is an important consideration for me, she seems nice, too. I sent her a pedantic and likely condescending email a while back and she responded with grace.
  11. D

    Who Hijacked ME?

    Good luck with that. PEM doesn't necessarily adhere to schedule. It even sometimes presents chronologically different depending on whether the exertion is physical vs mental. Precision in general for pwME would be great relative to PEM, but many of us suffer variations in how long after...
  12. D

    Survey of Anti-Pathogen Antibody Levels in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, 2022, Levine,Hanson et al

    I am a little concerned about their assumptions and inferences (and I'm a fan of this tandem +). Then again, I'm unclear about some specifics. Could they break out individual vs pooled? I apologize if I missed or forgot that. Main assumption that gnaws at me: Why assume a pathogen is not at...
  13. D

    The Occurrence of Hyperactivated Platelets and Fibrinaloid Microclots in ME/CFS, 2022, Nunes, Pretorius et al

    I'm having trouble reading the paper. Do these pwME have normal platelet counts? What happens if you have perpetually low platelet counts, and have some issues with clotting? I have ME/CFS and PEM, but I have low platelets, usually out of range low. I wonder if this matters. I am about to find...
  14. D

    Is tinnitus an ME symptom? - Discussion of evidence

    Look up Vickie Logan. Her singular case study almost dismantled Lyme orthodoxy. Before the medical case study, her story was just an anecdote. So one patient sans statistical associations can influence in a powerful fashion medical science.
  15. D

    Is tinnitus an ME symptom? - Discussion of evidence

    By reading. I then explain why reading levels the playing field, e.g., it provides readers with knowledge of those associations where they have been documented.
  16. D

    Is tinnitus an ME symptom? - Discussion of evidence

    Not sure what "So, patients read" means? It means pretty much everything clinicians can read, patients can read, and frequently do, and maybe some things clinicians haven't read. It means pwME are no more likely to have uninformed opinions about ME/CFS than clinicians - and usually are far...
  17. D

    Is tinnitus an ME symptom? - Discussion of evidence

    You cannot see the irony here? Conventional medicine has not allowed poor quality evidence to slow its momentum for years, and yet the responsibility lies with us? But I tell you that I suspect most here would have no problem accepting that. It's just that I'm not really clear on who decides...
  18. D

    Is tinnitus an ME symptom? - Discussion of evidence

    So, patients read. And don't be so fast to dismiss the power of anecdotes. It's what many case studies are all about, and case studies frequently defy large study results, and can help inform changes to orthodoxy.
Back
Top Bottom